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Introduction
Despite inroads in reducing smoking rates,1 exposure to tobacco 
smoke remains common.2 Over 12% of US adolescents remain active 
smokers3 and nearly half of US children are exposed to secondhand 
smoke (SHS).2 Even brief exposures to tobacco smoke may confer 
the majority of adverse health effects associated with active smok-
ing.4 How exposure to tobacco smoke increases the risk of car-
diovascular mortality remains under study but links to increased 
platelet reactivity and endothelial dysfunction,5–7 arterial stiffness 
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Abstract
Introduction: Despite reductions in smoking rates, exposure to cigarette smoke remains common 
among US children and adolescents. In adults, active smoking and secondhand smoke (SHS) exposure 
have been linked to adverse changes in lipid profiles and increases in inflammatory markers. Evidence 
that such changes are present before adulthood remains limited, and the extent to which active smoking 
and SHS exposure affect these cardiovascular measures in children has not been thoroughly assessed.
Methods: We employed data from 2008 individuals aged 12–19 years from the 2005–2010 National Health 
and Nutrition Examination Survey. Comparisons of the lipid and inflammatory marker levels among 
active smokers, those exposed to SHS (as determined by serum cotinine levels), and those unexposed 
to tobacco smoke were made using linear regression with multiple propensity score adjustment.
Results: Compared to unexposed children, lipid and inflammatory marker profiles did not dif-
fer among those exposed to SHS exposure. Among active smokers, differences compared to 
unexposed children were observed in triglyceride levels ( βˆ = 8.5 mg / dL , P = .01), the ratio of tri-
glycerides to high-density lipoprotein ( βˆ = 0.2 , P = .045), and low-density lipoprotein cholesterol  
( βˆ = -4.1 mg / dL , P = .03), though these did not reach levels of confirmatory statistical significance.
Conclusions: After accounting for sociodemographic characteristics and medical comorbidities, 
serum lipids and markers of systemic inflammation were not associated with SHS exposure. 
Tobacco smoke exposure in children may require longer durations of compounded effect before 
serum lipid abnormalities are detected.
Implications: This paper adds detail to the study of secondhand smoke’s effects on lipid profiles of 
children and adolescents. Prior research on this topic for these age groups has been limited, and 
this study provides national, cross-sectional data to show that both secondhand smoke and active 
smoking in childhood and adolescence is not associated with changes in lipid profiles or markers 
of inflammation. Tobacco smoke exposure may require longer durations of compounded effect 
before abnormalities are detected.
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and atherogenesis,5 inflammation,8–10 and oxidative stress4,11,12 are 
suspected.
Ties between SHS exposure and adverse lipid profiles have also 
been suggested. In adults, increases in low-density lipoprotein cho-
lesterol (LDL-C)13,14 and the ratio of total cholesterol to high-density 
lipoprotein cholesterol (HDL-C)4,15,16 as well as decreases in HDL-
C17 have been reported. Other proinflammatory markers, including 
homocysteine,4,9,10 fibrinogen,4,9,18 and C-reactive protein,4,9,10,18 also 
appear to be adversely affected by SHS.
Research in pediatrics has corroborated some, but not all, of these 
findings. Adolescents who actively smoke appear to have decreases in 
HDL-C similar in magnitude to that of adults,19–21 though data have 
been equivocal regarding LDL19,20 and total cholesterol.19,21 The poten-
tial untoward effects of SHS on cardiometabolic risk in children remain 
even more debated.22 In children, as with adults, SHS exposure has 
been linked by some to lower HDL-C23–25 levels, as well as increases 
in levels of apolipoprotein B,26 C-reactive protein,27,28 and the ratio of 
total cholesterol to HDL-C.24,25 Yet others have shown no difference in 
HDL-C26,29 and total cholesterol23,26 levels among those exposed to SHS. 
Many of these studies have been hampered by small sample sizes,23,25,30 
narrow age-ranges,24,27 limited racial and ethnic diversity,24,25 and a reli-
ance on self-reported SHS exposure.27 Alternative measures of cardio-
vascular risk (eg, non-HDL-C) that may be better predictors of adverse 
cardiovascular events in adulthood31,32 have often not been assessed.
To assess more comprehensively the association between chil-
dren’s cardiovascular risk profiles and tobacco smoke exposure, 
we examined recent data from the National Health and Nutrition 
Examination Survey. Using serum cotinine levels as an objective 
measure with which to measure individuals exposure to tobacco 
smoke, we employed a multiple propensity score-adjusted approach 
to adjust for nonequivalence between exposure groups.
Methods
Study Population
Data from 2008 subjects aged 12–19  years with available labora-
tory data from the 2005–2010 waves of continuous National Health 
and Nutrition Examination Survey were examined.33,34 Described 
elsewhere,35 National Health and Nutrition Examination Survey is 
a repeated cross-sectional, multistage, survey designed to assess the 
health status of the civilian, non-institutionalized US population. 
The study combined interview, laboratory, and physical examination 
components.35 Interviews were conducted in subjects’ homes; a par-
ent, guardian, or other household adult answered demographic and 
household questions. Physical examinations were conducted in mobile 
examination centers and included anthropomorphic measurements 
and a blood sample collection. Study protocols were approved by the 
National Center for Health Statistics institutional review board.35
Measures
Smoking Exposure
Serum cotinine, a measurable metabolite of nicotine and vali-
dated biomarker of both SHS exposure and active smoking, 
was employed.36 Consistent with prior studies,22,37,38 we defined 
individuals as active smokers if they had serum cotinine levels 
≥15.0 ng/ml or if participants reported using any product contain-
ing nicotine including cigarettes, pipes, cigars, chewing tobacco, 
snuff, nicotine patches, nicotine gum, or any other product con-
taining nicotine within the past 5 days. We classified those with a 
detectable serum cotinine (ie, ≥0.05 ng/ml) but <15 ng/ml but who 
did not report nicotine use within the last 5 days as exposed to 
SHS. Those with undetectable serum cotinine levels were classified 
as unexposed.
Laboratory Measures
Data from a subset of children asked to fast prior to the laboratory 
exam was employed. Measures of total cholesterol, HDL-C, LDL-C, tri-
glycerides, apolipoprotein B, and fasting glucose were obtained. LDL-C 
was calculated using the Friedenwald equation for those with triglyc-
eride levels ≤400 mg/dL.39 Non-HDL-C cholesterol was calculated as 
the difference between total cholesterol and HDL-C. High-sensitivity 
C-reactive protein (hsCRP) was measured in all participants using latex-
enhanced nephelometry; the lower limit of detection was 0.02 mg/dL.
Other Covariates
Demographic variables used to adjust for differences between groups 
included subjects’ age and ethnicity. In addition, body mass index, 
assessed by age- and sex-specific percentiles,40,41 was included. Blood 
pressure was also included, characterized by age- and sex-specific 
percentiles.42 Subjects were classified as having diabetes mellitus if 
the respondent reported being been told by a doctor that the child 
had diabetes mellitus, if the child used oral hypoglycemic agents or 
insulin, or if the child had a fasting serum glucose ≥126 mg/dL or 
HgbA1c ≥ 6.5%.43 Following prior work on diet’s effects on lipids,23 
dietary recall data was used to calculate the ratio of ingested satu-
rated fat and cholesterol to ingested calories.
Statistical Methodology
Since characteristics differed between smoking exposure groups, we 
pursued multiple propensity scores to adjust for such differences.44 
This approach expands on widely used methods for dichotomous 
treatment variables.45 Here, multiple propensity scores were esti-
mated from a multinomial logistic regression model in which tobacco 
smoke exposure status served as the dependent variable while the 
variables listed in Table  1 served as independent variables. Each 
propensity scores reflects the estimated probability of assignment to 
each tobacco smoke exposure status. To adjust for nonequivalence 
between groups, linear regression models were used to assess differ-
ences in means in cardiovascular risk factors by including two of 
the three estimated propensity scores. All analyses were conducted 
using Stata 11.2. Given the exploratory nature of the analysis, two-
sided P values are reported without adjustment for multiple testing. 
To ascertain whether threshold levels of cotinine exposure employed 
in our analysis influenced the results presented here, a sensitivity 
analysis examining low and high cotinine levels was conducted. 
Individuals classified as exposed to SHS were divided into low or 
high cotinine levels if they had levels below or above, respectively, 
the median cotinine value for that group.
Results
Significant differences in characteristics between exposure groups 
were noted. Shown in Table 1, subjects exposed to SHS were more 
likely than their unexposed peers to be male and overweight, and 
were more likely to have elevated blood pressure and diabetes. Active 
smokers were more likely than their nonsmoking peers to be older, 
white, and male, and to have elevated blood pressure. After adjust-
ment with propensity scores, balance in these covariates among the 
exposure groups improved.
Table 2 displays results from the unadjusted and adjusted compari-
sons of tobacco smoke exposure status and cardiovascular measures. 
After adjustment, no differences in lipid profiles among SHS-exposed 
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adolescents were observed. Adjusted results showed active smokers to 
have increased levels of triglycerides, the triglyceride-to-HDL-C ratio as 
well as mildly decreased LDL-C. It merits noting that, of these estimated 
relationships, only the association between smoking and triglyceride lev-
els approached near confirmatory statistical significance, which would 
incorporate the multiple comparisons made in our analysis (ie, a P value 
of .006 to preserve a Type I error rate of 0.05). Results of the sensitiv-
ity analysis corroborated the presented results (Supplementary Table 1).
Discussion
Despite consensus that tobacco smoke, including SHS, is associated 
with adverse cardiovascular consequences,5,11,17,46,47 conflicting evi-
dence exists as to whether the lipid profiles of children are adversely 
affected. Using a multiple propensity score approach, we report that 
tobacco smoke exposure was not materially associated with lipid 
profiles in a national sample of US children.
Our results differ in part from prior research, which merits com-
ment. Among adolescent smokers, no difference was observed in 
HDL-C levels, a focus of prior studies conducted in both adults48,49 
and adolescents.19–21 Our results examining active smokers also dif-
fer from prior work in that we found no differences in total cho-
lesterol levels.21 Most notably, our results suggest an increase in 
triglycerides and the triglyceride-HDL ratio among active smokers. 
As noted above, the relationship between smoking and increased 
triglycerides approach confirmatory statistical significance levels 
that would account for multiple comparisons. Such a finding comes 
amidst recent studies50,51 on children that suggest the ratio of triglyc-
erides to HDL-C may prove a superior marker of both increased 
arterial stiffness and cardiometabolic risk.49,50
While past studies have suggested associations between SHS 
exposure and decreased HDL-C levels,23–25,30 and SHS exposure and 
increased apolipoprotein B,26 our analysis found no such differences. 
Existing evidence suggests tobacco smoke exposure may provoke lipid 
Table 1. Demographic Characteristics (N = 2008)
Exposure status
Unexposed Secondhand smoke exposed Smokers P Adjusted P valuea
Age (mean ± SD) 14.9 ± 2.2 15.5 ± 2.3 17.5 ± 1.5 <.001 .49
Male, % 48.9 52.7 65.4 <.001 .99
Non-Hispanic white, % 25.7 26.2 44.0 <.001 .76
BMI, percentileb <.001 .32
 85th–94th 17.4 16.9 17.3
 ≥95th 16.3 25.2 19.8
Elevated BP, %c <.001 .97
 Pre-hypertensive 11.8 15.7 22.9
 Hypertensive 1.9 2.7 2.0
Diabetes, % 1.36 1.24 3.46 .02 .77
RISCC scored 18.6 ± 6.9 18.8 ± 7.1 18.2 ± 7.0 .55 .35
Cotinine, ng/ml (median, IQR) 0.02 (0.01–0.03) 0.26 (0.09–0.94) 82.3 (19.9–174) <.001 —e
BMI = body mass index; BP = blood pressure; IQR = interquartile range; RISCC = ratio of ingested saturated fat and cholesterol to calories.
aAdjusted with the use of multiple propensity scores.
bBMI percentiles shown are calculated as BMI-for-age percentiles from the 2000 CDC growth charts.
cElevated blood pressure follows definitions from the Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and 
Adolescents.
dThe RISCC is a single score that conveys the potential effect of diet on lipoproteins; it is calculated as: {(1.01 × saturated fat [in grams]) + (0.05 × cholesterol [in 
milligrams])} / (kcal/1000).
eCotinine is not included in the propensity score estimation since it is used to define exposure status.
Table 2. Differences in Mean Lipid and Inflammatory Markers, Unadjusted and With Adjustment by Multiple Propensity Scores (N = 2008)
Biomarkera
Unadjusted estimates (mean ± SD) Adjusted differences in means
Unexposed SHS Smokers
SHS Smokers
Diff. P Diff. P
Total cholesterol 158.9 ± 28.4 159.4 ± 31.9 160.3 ± 32.7 −0.5 .75 −2.7 .22
HDL-C 54.4 ± 12.8 53.4 ± 12.4 51.5 ± 13.9 0.3 .58 −0.3 .71
Non-HDL 104.5 ± 28.0 106.0 ± 31.3 108.8 ± 31.8* −0.8 .57 −2.4 .27
LDL-C 88.3 ± 24.4 89.7 ± 27.7 89.1 ± 26.5 −0.2 .85 −4.1 .03
Triglycerides 81.0 ± 44.2 81.4 ± 45.0 98.2 ± 56.6** −3.0 .19 8.5 .01
Triglyceride-HDL ratio 1.67 ± 1.26 1.70 ± 1.28 2.12 ± 1.52** −0.1 .18 0.2 .045
Apolipoprotein B 71.9 ± 18.4 73.2 ± 0.6 75.1 ± 20.6* −0.1 .91 −0.7 .61
C-reactive protein 0.17 ± 0.65 0.19 ± 0.49 0.18 ± 0.33 −0.1 .59 0.0 .36
HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; SHS = secondhand smoke.
aBiomarker values are in mg/dL, except triglyceride-HDL ratio, which is unitless.
*P < .05; **P < .001. Statistically significant differences from those unexposed are indicated.
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changes through oxidative damage to HDL-C particles, altering their 
metabolism, antioxidant properties, and reducing their capacity for 
lipid transport and potential atheroprotective properties.52 The timeline 
of such changes remains unclear, though some evidence suggests that 
these qualitative and functional changes to HDL-C may not only pre-
cede quantitative changes, but also result in paradoxically pro-athero-
genic HDL-C particles.53 Prior work that may provide insight into this 
timeline indicates that active adolescent smokers can show quantifiable 
changes in HDL-C within 1–2 years of smoking initiation,20 and may 
only show significant decreases in HDL-C when smoking more than 
three packs per week.54 In aggregate, these studies suggest that tobacco 
smoke exposure may not exert a quantifiable difference in serum lipids 
unless an individual is a long-term, active smoker. However, those 
exposed to tobacco smoke at lower levels may still be affected by a 
subclinical process of functional lipid alteration, which may be the pri-
mary mechanism underlying their increased cardiovascular risk.
Results regarding SHS and hsCRP also merit comment. Our 
results showed no association between hsCRP levels and SHS 
exposure. The association between SHS and hsCRP in children has 
previously been debated. Two prior studies demonstrated such an 
association27,28 but another,27 which adjusted for body mass index as 
we do here, found no association between SHS and hsCRP. Elevated 
CRP levels in active adolescent smokers have also been previously 
described,55 though no such effect was observed in our study.
Given the well-described adverse cardiovascular outcomes caused 
by smoking and SHS exposure, our results suggest that the mecha-
nism of those negative effects does not occur through substantive 
quantitative alterations in serum lipoproteins. Reviewed elsewhere, 
mounting evidence suggests that vascular endothelial dysfunction, 
and not serum lipids, may be the underlying etiology.18,49 Evidence 
has increasingly linked SHS exposure to markers of endothelial stress 
and decreased endothelial repair.56 Parental smoking, for example, 
has been linked to impaired brachial artery flow-mediated vasodila-
tion in children decades later.57 It remains tenable then that exposure 
to tobacco smoke has a cumulative effect on lipoprotein metabolism 
still undetectable in the pediatric population.
This study is also not, however, without its limitations. Cross-
sectional in nature, inferences are not causal. Random serum cotinine 
measurements have a limited ability to identify SHS exposure beyond 
a few days37 and may not wholly reflect the extent or frequency of 
smoking exposure. Residual confounding, by variables unaccounted 
for in our propensity score estimation, may exist and unexpectedly 
bias results. We were unable to incorporate physical activity levels, 
for example, given inconsistencies across survey waves. Total choles-
terol58 and HDL-C59 may change during puberty and correlate with 
androgen levels, which were unavailable in our current sample.
Yet our study has important strengths. It employed a large, 
racially diverse sample to assess smoke exposure and lipid profiles 
across a wide age range. In doing so, we used serum cotinine levels 
as a biochemical marker for nicotine exposure. In contrast to some 
prior studies that rely on self-report alone,23,25 this method is advan-
tageous by including those exposed to SHS but unaware of that 
exposure. Statistically, we employed a multiple propensity scores 
approach to balance likely confounders among the exposure groups.
In sum, we assessed the association between tobacco smoke, 
and lipid and inflammatory measures in a national sample of US 
children. We report that children exposed to tobacco smoke did not 
differ substantively in their profiles of lipoproteins or inflamma-
tory markers. Future studies investigating alternative mechanisms 
of cardiovascular risk including vascular endothelial damage and 
reactivity may provide insight into the pathogenesis of the increased 
cardiovascular morbidity associated with passive smoke exposure.
Supplementary Material
Supplementary Table  1 can be found online at http://www.ntr.
oxfordjournals.org
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